AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Editas Medicine, Inc. Director's Dealing 2017

May 31, 2017

33260_dirs_2017-05-31_78102f8f-8ada-4825-9244-a7458d0cdc89.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Editas Medicine, Inc. (EDIT)
CIK: 0001650664
Period of Report: 2017-05-30

Reporting Person: Hirsch Andrew (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	2000	Direct